Zimmer Trabecular Metal Total Ankle PMCF

Not Applicable

Active, not recruiting

• Conditions: Rheumatoid Arthritis; Post Traumatic Arthritis; Degenerative Arthritis
• Interventions: Device: Zimmer Trabecular Metal Total Ankle System

• Registration Number: NCT02038140
• Lead Sponsor: Zimmer Biomet

Brief Summary

The primary objective of this study is to obtain implant survivorship and clinical outcome data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary or revision total ankle arthroplasty. The assessment will include implant survivorship and clinical performance measured by pain and function, quality of life data, radiographic parameters and survivorship.

Detailed Description

The study design is a prospective, multicenter, study of the commercially available Zimmer Trabecular Metal Ankle semiconstrained implants. The study will require each site to obtain Institutional Review Board approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process.

All study subjects will undergo preoperative clinical evaluations prior to their primary or revision total ankle arthroplasty. The post-operative clinical and radiographic evaluations will be conducted at 6 weeks, 6 month, 1 year, 2, 3, 5, 7, and 10 years. Follow-up surveys will occur at 4, 6, 8, and 9 years.

Study Timeline

• Study First Submitted: 2014-01-14
• Study First Submitted QC: 2014-01-14
• Study First Posted: 2014-01-16
• Study Start: 2014-03
• Status Verified: 2025-03
• Last Update Submitted: 2025-03-11
• Last Update Posted: 2025-03-12
• Primary Completion: 2027-03
• Study Completion: 2027-03

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• The patient is > 18 years of age
• The patient is skeletally mature
• The patient qualifies for primary or revision total ankle replacement based on physical exam and medical history including the following: degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis.
• The patient is willing and able to provide written informed consent
• Patient is willing and able to cooperate in the required post-operative therapy
• The patient is willing and able to complete scheduled follow-up evaluations questionnaires as described in the Informed Consent
• The patient has participated in the Informed Consent process and has signed the Institutional Review Board/European Commission approved Informed Consent

Exclusion Criteria

• The patient is: a prisoner, mentally incompetent or unable to understand what participation in the study entails, a known alcohol or drug abuser, anticipated to be non-compliant.
• The patient has one of the following compromising the affected limb: ankle arthrodesis with malleolar exeresis, severe neurological or vascular disease, loss of musculature or neuromuscular compromise, severe instability, maltracking or misalignment of the tibia and talus uncorrectable by surgery.
• The patient has a local/systemic infection that may affect the prosthetic joint
• The patient has a previous history of infection in the affected joint
• The patient is known to be pregnant
• The patient has insufficient bone stock or bone quality to fix the components (i.e. osteoporosis, Charcot's disease)
• The patient has a known sensitivity or allergic reaction to one or more of the implanted materials
• The patient is unwilling or unable to give consent or to comply with the follow-up program

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Zimmer TM Total Ankle System	Zimmer Trabecular Metal Total Ankle System	Primary or revision total ankle arthroplasty subjects that receive the Zimmer Trabecular Metal Total Ankle System

Primary Outcome Measures

Name	Time	Method
Survivorship	10 years	Survival of the implants after 10 years which is based on removal of the prosthesis and will be determined using the Kaplan Meier Method.

Secondary Outcome Measures

Name	Time	Method
American Orthopaedic Foot and Ankle Society Score	First 2 years	Performance os the Zimmer Trabecular Metal Ankle after 2 years which is assessed by the AOFAS score.

Trial Locations

Locations (11)

Orthopaedic Associates of Grand Rapids REI; 🇺🇸 Grand Rapids, Michigan, United States

University California Davis; 🇺🇸 Sacramento, California, United States

OrthoCarolina Research Institute; 🇺🇸 Charlotte, North Carolina, United States

The Rothman Institute; 🇺🇸 Philadelphia, Pennsylvania, United States

Klinikverbund St. Antonius und St. Josef GmbH; 🇩🇪 Wuppertal, Germany

Inselspital-Stiftung Universitatsspital Bern; 🇨🇭 Bern, Switzerland

Spital StS AG; 🇨🇭 Thun, Switzerland

Duke University; 🇺🇸 Durham, North Carolina, United States

Humanitas San Pio X; 🇮🇹 Milan, Milano MI, Italy

Turku University Hospital Finland; 🇫🇮 Turku, Finland

UBC Providence Health Care Research Institute; 🇨🇦 Vancouver, British Columbia, Canada